Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net (loss) income	$ (113)	$ 2,841
Depreciation, amortization and other	1,399	900
Stock-based compensation expense	103	47
Deferred income taxes	(401)	(49)
Adjustments for equity method investments	(27)	(31)
Losses (gains) on equity securities	515	(1,830)
Other items, net	(95)	(60)
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables, net	486	(144)
Inventories	806	(58)
Other assets	(89)	(139)
Accounts payable	23	(253)
Accrued income taxes, net	223	443
Long-term tax liabilities	(715)	107
Accrued liabilities	(1,054)	(230)
Accrued sales incentives and allowance	(316)	(402)
Other liabilities	(56)	(78)
Net cash provided by operating activities	689	1,064
Cash flows from investing activities:
Proceeds from sales of marketable securities	0	1,124
Proceeds from maturities of marketable securities	0	550
Purchases of property, plant and equipment	(230)	(344)
Other	13	28
Net cash (used in) provided by investing activities	(217)	1,358
Cash flows from financing activities:
Net proceeds from issuance of debt	0	23,798
Extinguishment of debt	(410)	(420)
Repayment of debt	0	(704)
Dividends paid	(1,208)	(1,137)
Other	(90)	(28)
Net cash (used in) provided by financing activities	(1,708)	21,509
(Decrease) increase in cash and cash equivalents	(1,236)	23,931
Cash and cash equivalents at beginning of period	10,944	7,629
Cash and cash equivalents at end of period	$ 9,708	$ 31,560